This was the stock's third consecutive day of losses.

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rose 2.35% to $6.10 Tuesday, on what proved to be an all-around positive ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today the dosing of the first subject in the ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the ...

Signaturefd LLC lessened its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report ... Signaturefd LLC’s holdings in Syndax Pharmaceuticals were worth $27,000 as of its most ...

Cibc World Markets Corp acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ ... investors also recently modified their holdings of the company. Loomis Sayles & Co. L P acquired a ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Philip Morris International Inc ...